Allie Pharmaceutical: The company's drug Kangtizuoan Tablets have been approved for additional entrusted production enterprises.

MeiKo Pharmaceutical announced that the company recently received the "Drug Supplementary Application Approval Notice" and "Drug Clinical Trial Supplementary Application Approval Notice" issued by the National Medical Products Administration. The drug is named Itraconazole Tablets, with the trade name Yuxitai, and the approval includes adding Jiangsu Xuantai Pharmaceutical Co., Ltd. as the entrusted manufacturing company, using Itraconazole active pharmaceutical ingredient produced by Chongqing Boteng Pharmaceutical Technology Co., Ltd. for the commercial production of its tablets. In addition, the company's product MRX-5 tablets will add a new 200mg specification for further clinical trials, used for treating infections caused by non-tuberculous mycobacteria sensitive to this product.